amino acids; magnesium acetate; phosphoric acid; potassium acetate; sodium chloride
Drug data last refreshed 20h ago · AI intelligence enriched 1w ago
AMINOSYN 3.5% M is an injectable amino acid formulation with essential electrolytes (magnesium acetate, potassium acetate, sodium chloride, phosphoric acid) designed for parenteral nutritional support. It provides balanced amino acids and minerals for patients unable to receive nutrition orally or enterally, supporting protein synthesis and metabolic homeostasis.
As LOE approaches, commercial teams are likely contracting; competitive pressure (30/100) suggests moderate generic/alternative competition intensifying in the parenteral nutrition space.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on AMINOSYN 3.5% M offers limited growth trajectory due to LOE proximity and commodity market dynamics. Career value lies in hospital relationship management, formulary optimization, and cost-containment strategies rather than product innovation or market expansion.
Worked on AMINOSYN 3.5% M at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo